NPI: 1760624092 · PASADENA, CA 91107 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 04/01/2009
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 04/01/2009 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 16,148 | $3.30M |
| 2019 | 8,713 | $809K |
| 2020 | 9,031 | $776K |
| 2021 | 12,821 | $570K |
| 2022 | 10,434 | $654K |
| 2023 | 9,706 | $634K |
| 2024 | 8,315 | $486K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 46,661 | 3,927 | $6.73M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 13,720 | 1,445 | $303K |
| J1270 | Injection, doxercalciferol, 1 mcg | 3,633 | 447 | $115K |
| J1756 | Injection, iron sucrose, 1 mg | 2,888 | 1,014 | $31K |
| A4657 | Syringe, with or without needle, each | 2,243 | 1,093 | $29K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 405 | 242 | $5K |
| 83970 | 583 | 573 | $5K | |
| 82728 | 825 | 808 | $4K | |
| 83550 | 795 | 762 | $3K | |
| 83540 | 874 | 838 | $2K | |
| 85041 | 788 | 764 | $2K | |
| 85048 | 789 | 765 | $1K | |
| 90662 | 140 | 131 | $846.43 | |
| 0302 | 261 | 178 | $767.97 | |
| G0008 | Administration of influenza virus vaccine | 82 | 73 | $267.08 |
| 90674 | 18 | 16 | $28.23 | |
| 82108 | 52 | 52 | $0.00 | |
| 90670 | 16 | 16 | $0.00 | |
| 0250 | 360 | 25 | $0.00 | |
| G0009 | Administration of pneumococcal vaccine | 18 | 18 | $0.00 |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 17 | 12 | $0.00 |